Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus
Systemic Lupus Erythematosus (SLE), among many other auto-immune diseases, is known to be more prevalent in females than in males. This observation has served as the foundation for studies into how sex hormones may interact with the immune system to either drive or inhibit immune activation. Early s...
Main Authors: | Jessica M. Jones, Trine N. Jørgensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01271/full |
Similar Items
-
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models
by: Nassima Bekaddour, et al.
Published: (2024-12-01) -
Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
by: Karin Hjorton, et al.
Published: (2018-10-01) -
The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells
by: Karin Hjorton, et al.
Published: (2020-06-01) -
Lupus panniculitis as an initial manifestation of systemic lupus erythematosus
by: Patel Raksha, et al.
Published: (2010-01-01) -
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
by: Valentina Natoli, et al.
Published: (2023-08-01)